Cardinal Health raised to buy by Jefferies
Jefferies has upgraded Cardinal Health (CAH) to buy from hold, citing management's emerging EPS track record. Read more here.
Cardinal Health Inc. stock outperforms competitors on strong trading day
Shares of Cardinal Health Inc. CAH advanced 1.82% to $127.45 Wednesday, on what proved to be an all-around great trading ...
News Medical1d
Alcohol-related deaths and hospitalizations in Canada surged during the COVID-19 pandemic
Alcohol-related health issues surged during the COVID-19 pandemic, with a 17.6% rise in mortality, calling for enhanced ...
Cardinal Health upgraded to Buy from Hold at Jefferies
Jefferies analyst Brian Tanquilut upgraded Cardinal Health (CAH) to Buy from Hold with a price target of $150, up from $140. The firm thinks ...
Fierce Healthcare3d
Trump tariffs will escalate costs and disrupt the medical supply chain, industry execs warn
President Donald Trump on Saturday signed executive orders imposing sweeping tariffs on the country’s three largest trading ...
Dublin City Schools cancels plan to buy Cardinal Health building for $37 million
Draped in Mexican and Salvadoran flags, roughly 1,000 demonstrators gathered near City Hall shortly before noon, blocking ...
Cardinal Health price target raised to $150 from $144 at TD Cowen
TD Cowen raised the firm’s price target on Cardinal Health (CAH) to $150 from $144 and keeps a Buy rating on the shares. The firm said they ...
Mizuho raises Cardinal Health stock target to $142, keeps Outperform
Valiquette also increased his earnings per share (EPS) estimates for Cardinal Health (NYSE:CAH), raising the fiscal year 2025 forecast from $7.90 to $7.95 and the fiscal year 2026 projection from $8 ...